Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krogh Jensen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Haematologica|January 1, 1986
Low-dose cytosine arabinoside in the treatment of relapsed and refractory acute non-lymphocytic leukaemiaM Krogh Jensen, J Stentoft
Scandinavian Journal of Haematology|January 1, 1973
The induction of chromosome abnormalities by melphalan in rat bone marrow cellsG L Wantzin, M Krogh Jensen
Scandinavian Journal of Clinical and Laboratory Investigation|August 1, 1996
Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritisM Krogh Jensen, S Ekelund, L Svendsen
Leukemia & Lymphoma|July 21, 1998
Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expressionM Krogh-Jensen, P Johansen, F D'Amore
Mutation Research|April 1, 1976
Diphenylhydantoin and chromosome morphology in man and rat. A negative reportJ Alving, M Krogh Jensen, H Meyer
Acta Paediatrica Scandinavica|July 1, 1978
The absence of factor II in a child with systemic lupus erythematosusK B Lillquist, J Dyerberg, M Krogh-Jensen
Acta Medica Scandinavica|January 1, 1977
Bone changes during prednisone treatmentA Deding, L Tougaard, M Krogh Jensen, et al.
Ugeskrift for Laeger|November 25, 1974
[Letter: Treatment of patients with hemorrhagic disease--hemophilia]C C Arnoldi, M Bessermann-Nielsen, J Gormsen, et al.
Leukemia & Lymphoma|October 1, 1995
Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer RegistryM Krogh-Jensen, F D'Amore, M K Jensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFOM Krogh-Jensen, F d'Amore, M K Jensen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Haematologica|January 1, 1986
Low-dose cytosine arabinoside in the treatment of relapsed and refractory acute non-lymphocytic leukaemiaM Krogh Jensen, J Stentoft
Scandinavian Journal of Haematology|January 1, 1973
The induction of chromosome abnormalities by melphalan in rat bone marrow cellsG L Wantzin, M Krogh Jensen
Scandinavian Journal of Clinical and Laboratory Investigation|August 1, 1996
Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritisM Krogh Jensen, S Ekelund, L Svendsen
Leukemia & Lymphoma|July 21, 1998
Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expressionM Krogh-Jensen, P Johansen, F D'Amore
Mutation Research|April 1, 1976
Diphenylhydantoin and chromosome morphology in man and rat. A negative reportJ Alving, M Krogh Jensen, H Meyer
Acta Paediatrica Scandinavica|July 1, 1978
The absence of factor II in a child with systemic lupus erythematosusK B Lillquist, J Dyerberg, M Krogh-Jensen
Acta Medica Scandinavica|January 1, 1977
Bone changes during prednisone treatmentA Deding, L Tougaard, M Krogh Jensen, et al.
Ugeskrift for Laeger|November 25, 1974
[Letter: Treatment of patients with hemorrhagic disease--hemophilia]C C Arnoldi, M Bessermann-Nielsen, J Gormsen, et al.
Leukemia & Lymphoma|October 1, 1995
Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer RegistryM Krogh-Jensen, F D'Amore, M K Jensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFOM Krogh-Jensen, F d'Amore, M K Jensen, et al.
Pageof 1